🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
148,46 USD
Máx. histórico
156,92
14 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-5,39%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,24%
Cierre anterior
150,33
Rango de hoy
146,28 – 149,59
Volumen hoy
10.884.998
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 118,77 (puede no estar actualizado)
- Dividend yield
- 2,26% (puede no estar actualizado)
- Precio objetivo analistas
- 150,42 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 3 horas
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 12/03/2015 | 0,4294 USD |
| 11/12/2014 | 0,4294 USD |
| 11/09/2014 | 0,4198 USD |
| 12/06/2014 | 0,4198 USD |
| 13/03/2014 | 0,4198 USD |
| 12/12/2013 | 0,4198 USD |
| 12/09/2013 | 0,4103 USD |
| 13/06/2013 | 0,4103 USD |
| 13/03/2013 | 0,4103 USD |
| 13/12/2012 | 0,4103 USD |
| 13/09/2012 | 0,4008 USD |
| 13/06/2012 | 0,4008 USD |
| 13/03/2012 | 0,4008 USD |
| 13/12/2011 | 0,4008 USD |
| 13/09/2011 | 0,3626 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 04/10/2001 | 64,63 | 64,88 | 63,31 | 64,03 | -0,83% | 2,42% | 5.656.580 |
| 03/10/2001 | 65,31 | 65,31 | 63,24 | 64,56 | -1,14% | 3,17% | 6.080.601 |
| 02/10/2001 | 65,19 | 65,33 | 64,05 | 65,31 | +0,18% | 1,98% | 4.712.542 |
| 01/10/2001 | 63,79 | 65,19 | 63,60 | 65,19 | +2,58% | 2,50% | 8.254.886 |
| 28/09/2001 | 64,69 | 64,77 | 62,18 | 63,55 | +0,59% | 4,01% | 7.910.304 |
| 27/09/2001 | 61,05 | 63,87 | 60,96 | 63,18 | +4,51% | 4,77% | 6.885.150 |
| 26/09/2001 | 59,58 | 60,77 | 59,58 | 60,45 | +1,44% | 2,00% | 8.072.010 |
| 25/09/2001 | 60,11 | 61,07 | 58,06 | 59,59 | -2,41% | 5,00% | 12.446.362 |
| 24/09/2001 | 62,69 | 63,60 | 60,47 | 61,06 | -2,60% | 4,99% | 10.237.493 |
| 21/09/2001 | 61,07 | 64,11 | 60,87 | 62,69 | -1,72% | 5,31% | 13.921.842 |
| 20/09/2001 | 63,93 | 64,52 | 63,55 | 63,79 | -1,49% | 1,52% | 8.430.741 |
| 19/09/2001 | 65,79 | 66,07 | 63,50 | 64,75 | -0,66% | 3,90% | 9.043.611 |
| 18/09/2001 | 64,07 | 65,92 | 63,77 | 65,18 | +1,73% | 3,35% | 7.641.178 |
| 17/09/2001 | 64,84 | 64,98 | 63,12 | 64,07 | +1,59% | 2,87% | 9.532.084 |
| 10/09/2001 | 61,07 | 63,45 | 60,60 | 63,07 | +2,80% | 4,67% | 5.744.088 |
| 07/09/2001 | 62,36 | 62,36 | 61,21 | 61,36 | -2,21% | 1,84% | 5.074.206 |
| 06/09/2001 | 64,12 | 64,48 | 62,51 | 62,74 | -2,88% | 3,08% | 5.254.358 |
| 05/09/2001 | 62,33 | 64,79 | 61,74 | 64,60 | +3,68% | 4,90% | 6.785.800 |
| 04/09/2001 | 62,21 | 63,44 | 62,07 | 62,31 | +0,31% | 2,19% | 6.548.009 |
| 31/08/2001 | 62,64 | 63,72 | 61,79 | 62,12 | -1,35% | 3,08% | 4.100.824 |
| 30/08/2001 | 63,60 | 64,59 | 62,64 | 62,97 | -1,71% | 3,06% | 4.400.866 |
| 29/08/2001 | 64,79 | 65,26 | 63,98 | 64,06 | -1,28% | 1,97% | 3.345.006 |
| 28/08/2001 | 65,12 | 66,04 | 64,80 | 64,90 | -1,00% | 1,90% | 3.458.924 |
| 27/08/2001 | 65,65 | 66,24 | 65,27 | 65,55 | -0,46% | 1,48% | 3.279.192 |
| 24/08/2001 | 64,89 | 66,08 | 64,60 | 65,86 | +0,74% | 2,28% | 5.523.170 |
| 23/08/2001 | 66,89 | 67,08 | 64,93 | 65,37 | -3,81% | 3,21% | 9.797.962 |
| 22/08/2001 | 66,75 | 67,98 | 65,98 | 67,96 | +0,66% | 2,99% | 6.877.919 |
| 21/08/2001 | 67,06 | 68,23 | 66,56 | 67,51 | +0,24% | 2,49% | 4.574.415 |
| 20/08/2001 | 66,17 | 67,56 | 66,17 | 67,35 | +2,07% | 2,09% | 4.837.463 |
| 17/08/2001 | 66,79 | 67,02 | 65,47 | 65,98 | -1,20% | 2,33% | 3.808.432 |